ENDONOVO THERAPEUTICS, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, other for the quarter ending 2023-03-31 was $24.87K.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, other for the quarter ending 2019-09-30 was $3.79K.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, other for the quarter ending 2019-03-31 was $8.33K, a 696.65% increase year-over-year.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, other for the quarter ending 2018-03-31 was $1.05K.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, other for fiscal 2019 was $8.33K, a 51.54% decline from fiscal 2018.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, other for fiscal 2018 was $17.19K.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, other for fiscal 2016 was $107.08K, a 23.02% decline from fiscal 2015.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, other for fiscal 2015 was $139.09K, a 53.88% decline from fiscal 2014.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2023-03-31 | $24.87K 10-Q · filed 2023-12-29 | |
| 2019-12-31 | $8.33K 10-K · filed 2021-04-13 | |
| 2019-09-30 | $3.79K 10-Q · filed 2019-11-19 | |
| 2019-03-31 | $8.33K 10-Q · filed 2020-11-19 | |
| 2018-12-31 | $17.19K 10-K · filed 2020-05-04 | |
| 2018-03-31 | $1.05K 10-Q · filed 2019-11-19 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-06 | $107.08K 10-K · filed 2018-04-06 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | |
| 2015-12-31 | -$774.05K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-17 | $139.09K 10-K · filed 2017-04-17 |
| 2015-09-30 | $585.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-23 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | |
| 2015-03-31 | $328.14K 10-Q · filed 2015-06-15 | |
| 2014-12-31 | $301.60K 10-K · filed 2016-05-17 |